Jeff Geschwind, MD: Global Clinical Research Impact Through NAMSA and USA Clinics Group, Jeff Geschwind, MD, leads international clinical trials, fast-tracking breakthrough cancer therapies from labs to patients worldwide. https://www.onclive.com/authors/jeff-geschwind-md-johns-hopkins